CING Cingulate Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Cingulate (CING) Stock: Buy, Sell, or Hold?

$4.71
+0.96 (+25.60%) ▲
5d: +3.29% 30d: +8.03% 90d: -10.63%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (55%)
Quality Score
43/100
Position
FAIR
30-Day Fair Range
$4.31 – $5.04
Position: FAIR
Forward P/E & Valuation
-4.3x
Next 12M consensus est.
Wall Street Target
$21.20
+465.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.65 / $5.00
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: CING is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When CING Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CING is currently trading at $4.71, which is considered fair relative to its 30-day fair value range of $4.31 to $5.04.

Technical Outlook: Technically, CING is in a downtrend. Immediate support is located at $3.65, while resistance sits at $5.00. The stock is showing strong short-term momentum, up 25.6% recently.

Market Sentiment: CING scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.20 (+465.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.31 - $5.04
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 55.3%

Trading Range & Key Levels

30-Day Trading Range $4.31 - $5.04
Current vs Trading Range FAIR
Support Level $3.65
Resistance Level $5.00
Current Trend Downtrend
Technical data as of Nov 16, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 170d (53% conf)

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+25.6%)
  • BULLISH: Trading 465.3% below Wall St target ($21.20)
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -4.26
Wall Street Target $21.20 (+465.3%)
Share CING Analysis

Share this live CING analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CING)

Bearish 4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 17, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate strong bullish sentiment towards $CING, with traders expecting a sustained rise above $4. There is also anticipation for potential parabolic moves in a related low float China stock, EZGO.
Key Retail Themes: Bullish sentiment towards $CING Anticipation for parabolic moves in EZGO
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 1:48 PM ET
Data refreshes hourly during market hours. Next update: 2:48 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CING.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 47 HOLD
ARGX
argenx NV ADR
STRONG BUY
24 analysts
$1147 45 HOLD
SYRE
Spyre Therapeutics Inc.
STRONG BUY
18 analysts
$124 48 HOLD
BNTX
BioNTech SE
BUY
21 analysts
$112 61 BUY
DNTH
Dianthus Therapeutics Inâ€Ļ
STRONG BUY
18 analysts
$139 35 SELL
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals